Long-QT syndrome

Cardiology in Review

Volumn 19, Issue 5, 2011, Pages 217-225

  Kramer, Daniel B ^a   Zimetbaum, Peter J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

long QT syndrome; sudden cardiac death

Indexed keywords

ENVIRONMENTAL FACTOR; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HEREDITY; HUMAN; LONG QT SYNDROME; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; SUDDEN DEATH;

ACTION POTENTIALS; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HUMANS; LONG QT SYNDROME; PROGNOSIS; TORSADES DE POINTES;

EID: 80051740973     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0b013e3182203504     Document Type: Review

References (52)

1. Poelzing S, Rosenbaum DS. Nature, significance, and mechanisms of electrical heterogeneities in ventricle. Anat Rec A Discov Mol Cell Evol Biol. 2004;280:1010-1017. (Pubitemid 39319325)
2. Greenstein JL, Wu R, Po S, et al. Role of the calcium-independent transient outward current I (to1) in shaping action potential morphology and duration. Circ Res. 2000;87:1026-1033.
3. Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol. 1993;72:23B-25B (Pubitemid 23249060)
4. Benatar A, Decraene T. Comparison of formulae for heart rate correction of QT interval in exercise ECGs from healthy children. Heart. 2001;86:199-202. (Pubitemid 32983491)
5. Bradley TJ, Metzger DL, Sanatani S. Long on QT and low on calcium. Cardiol Young. 2004;14:667-670.
6. Benoit SR, Mendelsohn AB, Nourjah P, et al. Risk factors for prolonged QTc among us adults: third national health and nutrition examination survey. Eur J Cardiovasc Prev Rehabil. 2005;12:363-368. (Pubitemid 41192168)
7. Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. 1993;270:2590-2597. (Pubitemid 23346699)
8. Nakagawa M, Ooie T, Takahashi N, et al. Influence of menstrual cycle on QT interval dynamics. Pacing Clin Electrophysiol. 2006;29:607-613. (Pubitemid 43886612)
9. Burke JH, Ehlert FA, Kruse JT, et al. Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol. 1997;79:178-181. (Pubitemid 127673706)
10. Yang T, Roden DM. Extracellular potassium modulation of drug block of IKR. Implications for torsade de pointes and reverse use-dependence. Circulation. 1996;93:407-411.
11. Ray WA, Murray KT, Meredith S, et al. Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med. 2004;351:1089-1096.
12. Antzelevitch C, Sicouri S. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and torsade de pointes. J Am Coll Cardiol. 1994;23:259-277. (Pubitemid 24027219)
13. Antzelevitch C, Sun ZQ, Zhang ZQ, et al. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. J Am Coll Cardiol. 1996;28:1836-1848.
14. Abildskov JA, Lux RL. Mechanisms in adrenergic dependent onset of torsades de pointes. Pacing Clin Electrophysiol. 1997;20:88-94. (Pubitemid 27053878)
15. Tanabe Y, Inagaki M, Kurita T, et al. Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in lQT1 than lQT2 forms of congenital long QT syndrome. J Am Coll Cardiol. 2001;37:911-919. (Pubitemid 32202463)
16. Vyas H, Hejlik J, Ackerman MJ. Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response. Circulation. 2006;113:1385-1392. (Pubitemid 43739434)
17. Amin AS, Tan HL, Wilde AA. Cardiac ion channels in health and disease. Heart Rhythm. 2010;7:117-126.
18. Ruan Y, Liu N, Napolitano C, et al. Therapeutic strategies for long-QT syndrome: does the molecular substrate matter? Circ Arrhythm Electrophysiol. 2008;1:290-297.
19. Kannankeril P, Roden DM, Darbar D. Drug-induced long QT syndrome. Pharmacol Rev. 2010;62:760-781.
20. Kannankeril PJ, Norris KJ, Carter S, et al. Factors affecting the degree of QT prolongation with drug challenge in a large cohort of normal volunteers. Heart Rhythm. In press.
21. Schwartz PJ. Idiopathic long QT syndrome: progress and questions. Am Heart J. 1985;109:399-411. (Pubitemid 16248481)
22. Schwartz PJ, Moss AJ, Vincent GM, et al. Diagnostic criteria for the long QT syndrome. An update. Circulation. 1993;88:782-784. (Pubitemid 23228078)
23. Hofman N, Wilde AA, Kaab S, et al. Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system? Eur Heart J. 2007;28:575-580. (Pubitemid 47355496)
24. Eggeling T, Hoeher M, Osterhues HH, et al. Significance of noninvasive diagnostic techniques in patients with long QT syndrome. Am J Cardiol. 1992;70:1421-1426.
25. Dillenburg RF, Hamilton RM. Is exercise testing useful in identifying congenital long QT syndrome? Am J Cardiol. 2002;89:233-236. (Pubitemid 34134005)
26. Garson A Jr, Dick M II, Fournier A, et al. The long QT syndrome in children An international study of 287 patients. Circulation. 1993;87:1866-1872. (Pubitemid 23165628)
27. Walker BD, Krahn AD, Klein GJ, et al. R. Burst bicycle exercise facilitates diagnosis of latent long QT syndrome. Am Heart J. 2005;150:1059-1063. (Pubitemid 41607798)
28. Takenaka K, Ai T, Shimizu W, et al. Exercise stress test amplifies genotypephenotype correlation in the lQT1 and lQT2 forms of the long-QT syndrome. Circulation. 2003;107:838-844. (Pubitemid 36241041)
29. Schwartz PJ, Priori SG, Locati EH, et al. Long QT syndrome patients with mutations of the scn5a and HERG genes have differential responses to Na + channel blockade and to increases in heart rate: implications for gene-specific therapy. Circulation. 1995;92:3381-3386.
30. Eggeling T, Osterhues HH, Hoeher M, et al. Value of Holter monitoring in patients with the long QT syndrome. Cardiology. 1992;81:107-114. (Pubitemid 23052120)
31. Lupoglazoff JM, Denjoy I, Berthet M, et al. Notched T waves on Holter recordings enhance detection of patients with lQT2 (HERG) mutations. Circulation. 2001;103:1095-1101. (Pubitemid 32200183)
32. Ackerman MJ, Khositseth A, Tester DJ, et al. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc. 2002;77:413-421. (Pubitemid 34465148)
33. Shimizu W, Ohe T, Kurita T, et al. Differential response of QTu interval to exercise, isoproterenol, and atrial pacing in patients with congenital long QT syndrome. Pacing Clin Electrophysiol. 1991;14:1966-1970.
34. Katagiri-Kawade M, Ohe T, Arakaki Y, et al. Abnormal response to exercise, face immersion, and isoproterenol in children with the long QT syndrome. Pacing Clin Electrophysiol. 1995;18:2128-2134. (Pubitemid 26014236)
35. Priori SG, Barhanin J, Hauer RN, et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts 1 and 2. Circulation. 1999;99:518-528. (Pubitemid 29061867)
36. Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome: a prospective international study. Circulation. 1985;71:17-21. (Pubitemid 15164757)
37. Locati EH, Zareba W, Moss AJ, et al. Age-and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the international lQTS registry. Circulation. 1998;97:2237-2244. (Pubitemid 28265385)
38. Schwartz PJ, Locati E. The idiopathic long QT syndrome: pathogenetic mechanisms and therapy. Eur Heart J. 1985;6(suppl D):103-114. (Pubitemid 16172260)
39. Splawski I, Shen J, Timothy KW. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation. 2000;102:1178-1185.
40. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:89-95. (Pubitemid 32050441)
41. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003;348:1866-1874. (Pubitemid 36532312)
42. Moss AJ, Robinson JL, Gessman L, et al. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol. 1999;84:876-879. (Pubitemid 29475069)
43. Wilde AA, Jongbloed RJ, Doevendans PA, et al. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (lQTS2) patients from KVLQT1-related patients (LQTS1). J Am Coll Cardiol. 1999;33:327-332. (Pubitemid 29234193)
44. Schwartz PJ, Spazzolini C, Crotti L, et al. The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation. 2006;113:783-790.
45. Assimes TL, Malcolm I. Torsade de pointes with sotalol overdose treated successfully with lidocaine. Can J Cardiol. 1998;14:753-756. (Pubitemid 28276717)
46. Takanaka C, Ogunyankin KO, Sarma JS, et al. Antiarrhythmic and arrhythmogenic actions of varying levels of extracellular magnesium: possible cellular basis for the differences in the efficacy of magnesium and lidocaine in torsade de pointes. J Cardiovasc Pharmacol Ther. 1997;2:125-134. (Pubitemid 27288591)
47. Aiba T, Shimizu W, Inagaki M, et al. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil. J Am Coll Cardiol. 2005;45:300-307. (Pubitemid 40094741)
48. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm society. Circulation. 2006;114:e385-e484.
49. Moss AJ, Zareba W, Hall WJ, et al. Effectiveness and limitations of betablocker therapy in congenital long-QT syndrome. Circulation. 2000;101:616-623. (Pubitemid 30094732)
50. Schwartz PJ, Priori SG, Cerrone M, et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004;109:1826-1833. (Pubitemid 38509115)
51. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACCc/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the American association for thoracic surgery and society of thoracic surgeons. Circulation. 2008;117:e350-e408. (Pubitemid 351771339)
52. Chatrath R, Porter CB, Ackerman MJ. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults. Mayo Clin Proc. 2002;77:226-231. (Pubitemid 34177597)